Seung Dong BAEK - Kim & Chang

Profile

Experience

Kim & Chang (2019-Present)

Visiting Lawyer, Sullivan & Cromwell LLP, New York (2022-2023)

Shin & Kim (2016-2019)

Representative Mattersshow

Represented an EU Private Equity Fund (“PEF”) in the acquisition of a lens manufacturing company.
Represented a PEF in the minority share acquisition of a pharmaceutical company.
Represented a PEF in the acquisition and the divestiture of an advanced material manufacturing company.
Represented a fintech company in multiple series of equity funding.
Represented a US medical device manufacturing company in the acquisition of a medical device manufacturing company.
Represented a US PEF in the acquisition of a medical device manufacturing company.
Represented a PEF in the acquisition of an online commerce company.
Represented a Hong Kong PEF in the acquisition of a food delivery platform company.
Represented a PEF in the minority share acquisition of a lubricant manufacturing company.
Represented a PEF in the minority share acquisition of a mobility platform company.
Represented a PEF in the divestiture of an urban gas company.
Represented a Hong Kong PEF in the minority share acquisition of a contact center company.
Represented an internet platform company in a joint venture establishment with an internet platform company overseas.
Represented a PEF in the divestiture of an environmental services company.
Represented a display manufacturing company in the divestiture of its manufacturing subsidiaries overseas.
Represented a PEF in the acquisition of a tour service company.
Represented a conglomerate in the divestiture of an electric vehicle battery materials manufacturing company.
Represented a PEF in the acquisition of an oral medical device manufacturing company.
Provides advice on all aspects of corporate law, including the operation of a company’s board of directors and general meetings of shareholders.
Provides advice on a wide range of governance issues, including regulatory compliance and risk management, to strengthen shareholder relations and respond to activism challenges.